Response to Somay et al. Letter to the Editor Regarding "Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy"

Integr Cancer Ther. 2023 Jan-Dec:22:15347354231167367. doi: 10.1177/15347354231167367.

Authors

Kerstin Faravel¹, Marta Jarlier¹, Pierre Senesse^{1

2}, Marie-Eve Huteau¹, Chloé Janiszewski¹, Anne Stoebner^{1

2}, Pierre Boisselier¹

Affiliations

¹ Cancer Institute of Montpellier, University of Montpellier, Montpellier, France.
² University of Montpellier INSERM, IRCM, IDESP, UMR 1302, Montpellier, France.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Chemoradiotherapy / adverse effects
Head and Neck Neoplasms* / drug therapy
Humans
Trismus* / etiology

Associated data

ClinicalTrials.gov/NCT03979924